Matteo Duca

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Top Venues

JCO precision oncology

Exploration of targeted anti-tumor therapy

Clinical cancer research : an official journal of the American Association for Cancer Research

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Vingiani, Luca Agnelli, Matteo Duca, Daniele Lorenzini, Silvia Damian, Claudia Proto, Monica Niger, Federico Nichetti, Elena Tamborini, Federica Perrone, Alberta Piccolo, Siranoush Manoukian, Jacopo Azzollini, Marta Brambilla, Elena Colombo, Salvatore Lopez, Claudio Vernieri, Francesca Marra, Elena Conca, Adele Busico, Iolanda Capone, Fabio Bozzi, Marta Angelini, Andrea Devecchi, Rebecca Salvatori, Valentina De Micheli, Anna Baggi, Silvia Pasini, Claudio Jommi, Vito Ladisa, Giovanni Apolone, Filippo De Braud, Giancarlo Pruneri
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care. JCO precision oncology 7 (2023)
Iolanda Capone, Fabio Bozzi, Gian Paolo Dagrada, Paolo Verderio, Elena Conca, Adele Busico, Maria Adele Testi, Valentina Monti, Matteo Duca, Claudia Proto, Silvia Damian, Alberta Piccolo, Federica Perrone, Elena Tamborini, Andrea Devecchi, Paola Collini, Daniele Lorenzini, Andrea Vingiani, Luca Agnelli, Giancarlo Pruneri
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples. Exploration of targeted anti-tumor therapy 3 (5) (2022)
Matteo Duca, Darren Wan-Teck Lim, Vivek Subbiah, Shunji Takahashi, John Sarantopoulos, Andrea Varga, Joseph A D'Alessio, Tinya Abrams, Qing Sheng, Eugene Youchin Tan, Maria Santos Rosa, Juan Gonzalez-Maffe, Janna Sand-Dejmek, Claire Fabre, Miguel Martin
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors. Molecular cancer therapeutics 21 (4) (2022)
Sylvie Rottey, Jeffrey Clarke, Kyaw Aung, Jean-Pascal Machiels, Ben Markman, Kimberley M Heinhuis, Michael Millward, Martijn Paul Lolkema, Sandip Pravin Patel, Paul de Souza, Matteo Duca, Curigliano Giuseppe, Armando Santoro, Takafumi Koyama, Michelle Brown, Heather Vezina, Chunsheng He, Quincy Siu-Chung Chu
Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody-drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)